tiprankstipranks
Advertisement
Advertisement

REGN Stock Latest News

Regeneron’s Cemiplimab Combo Trial With SNS-101 Reaches Completion: What Investors Should Watch
Company AnnouncementsRegeneron’s Cemiplimab Combo Trial With SNS-101 Reaches Completion: What Investors Should Watch
5d ago
REGN
Veeva price target raised to $310 from $270 at Needham
PremiumThe Fly
Veeva price target raised to $310 from $270 at Needham
11d ago
LLY
BIIB
Regeneron and Sanofi Advance IL-33 Strategy With Completed Rhinosinusitis Trial
PremiumCompany Announcements
Regeneron and Sanofi Advance IL-33 Strategy With Completed Rhinosinusitis Trial
13d ago
REGN
Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims
PremiumMarket News
Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims
17d ago
REGN
Regeneron’s Olatorepatide Trial Signals a Bid for Obesity Market Upside
PremiumCompany Announcements
Regeneron’s Olatorepatide Trial Signals a Bid for Obesity Market Upside
18d ago
REGN
Private Markets: $1B for Base Power, $545M for Whatnot
PremiumThe FlyPrivate Markets: $1B for Base Power, $545M for Whatnot
18d ago
U
GD
Regeneron’s Pasatru granted FDA approval for FOP
Premium
The Fly
Regeneron’s Pasatru granted FDA approval for FOP
18d ago
REGN
Regeneron price target raised to $824 from $641 at Leerink
Premium
The Fly
Regeneron price target raised to $824 from $641 at Leerink
21d ago
REGN
Private Markets: Databricks secures $5B as Kalshi targets $40B valuation
PremiumThe Fly
Private Markets: Databricks secures $5B as Kalshi targets $40B valuation
22d ago
AI
IBM
The Week That Was, The Week Ahead: Macro and Markets, August 16
PremiumMarket News
The Week That Was, The Week Ahead: Macro and Markets, August 16
22d ago
AS
AU
Regeneron Targets Cat Allergy Eye Relief With New Phase 3 Antibody Trial
PremiumCompany Announcements
Regeneron Targets Cat Allergy Eye Relief With New Phase 3 Antibody Trial
26d ago
REGN
Regeneron announces Health Canada approval of new indication for Libtayo
PremiumThe Fly
Regeneron announces Health Canada approval of new indication for Libtayo
1M ago
REGN
Regeneron Targets Next‑Gen Cancer Immunotherapy With New Phase 1/2 Trial
PremiumCompany AnnouncementsRegeneron Targets Next‑Gen Cancer Immunotherapy With New Phase 1/2 Trial
1M ago
REGN
Regeneron price target raised to $1,030 from $1,000 at Guggenheim
Premium
The Fly
Regeneron price target raised to $1,030 from $1,000 at Guggenheim
1M ago
REGN
Regeneron price target raised to $740 from $700 at Citi
Premium
The Fly
Regeneron price target raised to $740 from $700 at Citi
1M ago
REGN
Regeneron and Sanofi Terminate Real‑World Dupilumab Study in Chronic Urticaria
PremiumCompany Announcements
Regeneron and Sanofi Terminate Real‑World Dupilumab Study in Chronic Urticaria
1M ago
SNY
REGN
Regeneron price target raised to $737 from $696 at RBC Capital
PremiumThe Fly
Regeneron price target raised to $737 from $696 at RBC Capital
1M ago
SNY
REGN
Regeneron price target raised to $758 from $730 at Morgan Stanley
PremiumThe Fly
Regeneron price target raised to $758 from $730 at Morgan Stanley
1M ago
REGN
Regeneron price target raised to $891 from $856 at BofA
PremiumThe Fly
Regeneron price target raised to $891 from $856 at BofA
1M ago
REGN
Regeneron price target raised to $795 from $750 at Cantor Fitzgerald
PremiumThe FlyRegeneron price target raised to $795 from $750 at Cantor Fitzgerald
1M ago
REGN
Regeneron price target raised to $761 from $742 at Baird
Premium
The Fly
Regeneron price target raised to $761 from $742 at Baird
1M ago
REGN
Regeneron price target raised to $750 from $700 at Wells Fargo
Premium
The Fly
Regeneron price target raised to $750 from $700 at Wells Fargo
1M ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >